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Abstract 
 
Gene expression data have been analyzing by many researchers by using a 
range of computational intelligence methods. From the gene expression data, 
selecting a small subset of informative genes can do cancer classification. Nev-
ertheless, many of the computational methods face difficulties in selecting small 
subset since the small number of samples needs to be compared to the huge 
number of genes (high-dimension), irrelevant genes and noisy genes. Hence, to 
choose the small subset of informative genes that is significant for the cancer 
classification, an enhanced binary particle swarm optimization is proposed. 
Here, the constraint of the elements of particle velocity vectors is introduced 
and a rule for updating particle’s position is proposed. Experiments were per-
formed on five different gene expression data. As a result, in terms of classifica-
tion accuracy and the number of selected genes, the performance of the intro-
duced method is superior compared to the conventional version of binary parti-
cle swarm optimization (BPSO). The other significant finding is lower running 
times compared to BPSO for this proposed method.   
Keywords: Binary particle swarm optimization, gene selection, gene expres-
sion data, optimization. 
1 Introduction 
Advances in microarray technology allow scientists to measure the expression levels 
of thousands of genes simultaneously in biological organisms and have made it possi-
ble to create databases of cancerous tissues. It finally produces gene expression data 
that contain useful information of genomic, diagnostic, and prognostic for researchers 
[3]. Thus, there is a need to select informative genes that contribute to a cancerous 
state [5]. However, the gene selection process poses a major challenge because of the 
following characteristics of the data: the huge number of genes compared to the small 
number of samples (high-dimensional data), irrelevant genes, and noisy data. To 
overcome this challenge, a gene selection method is used to select a subset of infor-
mative genes that maximizes classifier’s ability to classify samples more accurately 
[6]. In computational intelligence domains, gene selection is called feature selection.  
Recently, several gene selection methods based on particle swarm optimization 
(PSO) have been proposed to select informative genes from gene expression data 
[4],[7]-[10]. PSO is a new evolutionary technique proposed by Kennedy and Eberhart 
[1]. Shen et al. have proposed a hybrid of PSO and tabu search approaches for gene 
selection [7]. However, the results obtained by using the hybrid method are less 
meaningful since the application of tabu approaches in PSO is unable to search a 
near-optimal solution in search spaces. Next, Li et al. have introduced a hybrid of 
PSO and genetic algorithms (GA) for the same purpose [4]. Unfortunately, the accu-
racy result is still not high and many genes are selected for cancer classification since 
there are no direct probability relations between GA and PSO.  
Next, Chuang et al. proposed an improved binary PSO [8]. 100% classification ac-
curacy in many data sets had been yielded by using the proposed method, but it util-
ized a large number of selected genes (large gene subset) to obtain the high accuracy. 
This method used a large number of genes because the global best particle was reset 
to the zero position when its fitness values did not change after three consecutive 
iterations. Chuang et al. [9],[10] introduced a combination of tabu search and PSO for 
gene selection [9], and currently they proposed a hybrid of BPSO and a combat GA 
for the same purpose [10]. However, both proposed approaches still need a high num-
ber of selected to result high classification accuracy. A significant weakness was 
found resulting from the combination of PSO and tabu search or a combat GA which 
did not share probability significance in their processes. Generally, the PSO-based 
methods are intractable to efficiently produce a small (near-optimal) subset of infor-
mative genes for high classification accuracy [4],[7]-[10]. This is mainly because the 
total number of genes in gene expression data is too large (high-dimensional data). 
The diagnostic goal is to develop a medical procedure based on the least number of 
possible genes that needed to detect diseases. Thus, we introduce an enhancement of 
binary PSO based on the proposed constraint and rule (CPSO) to select a small (near-
optimal) subset of informative genes that is most relevant for the cancer classification. 
The small subset means that it contains the small number of selected genes. In order 
to test the effectiveness of our proposed method, we apply CPSO to five gene expres-
sion data sets, including binary-classes and multi-classes data sets. 
This paper is organized as follows. In Section 2 and Section 3, we briefly describe 
the conventional version of binary PSO and CPSO, respectively. Section 4 presents 
data sets used and experimental results. Section 5 summarizes this paper by providing 
its main conclusions and addresses future developments. 
2 The Conventional Version of Binary PSO (BPSO) 
BPSO is initialized with a population of particles. At each iteration, all particles 
move in a problem space to find the optimal solution. A particle represents a potential 
solution in an n-dimensional space. Each particle has position and velocity vectors for 
directing its movement. The position vector and velocity vector of the ith particle in 
the n-dimension can be represented as X
i
= (x
i
1,x
i
2,...,x
i
n ) and V
i
= (v
i
1,v
i
2,...,v
i
n ) , re-
spectively, where x
i
d Î{0,1};  i=1,2,..m (m is the total number of particles); and 
d=1,2,..n (n is the dimension of data) [2]. v
i
d
 represent an element of particle velocity 
vectors. It is a real number for the d-th dimension of the particle i, where the maxi-
mum v
i
d
, V
max
= (1/ 3)´n. 
In gene selection, the vector of particle positions is represented by a binary bit 
string of length n, where n is the total number of genes. Each position vector (X
i
) 
denotes a gene subset. If the value of the bit is 1, it means that the corresponding gene 
is selected. Otherwise, the value of 0 means that the corresponding gene is not se-
lected. Each particle in the t-th iteration updates its own position and velocity accord-
ing to the following equations: 
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where c
1
 and c
2
 are the acceleration constants in the interval [0,2]. 
r
1
d (t),r
2
d (t),r
3
d (t) ~U (0,1)  are random values in the range [0,1] that sampled from a 
uniform distribution. Pbest
i
(t) = (pbest
i
1(t), pbest
i
2(t),..., pbest
i
n(t))  and 
Gbest(t) = (gbest1(t),gbest2(t),...,gbestn (t))  represent the best previous position of 
the ith particle and the global best position of the swarm (all particles), respectively. 
They are assessed base on a fitness function. Sig(v
i
d (t +1)) is a sigmoid function 
where  Sig(v
i
d (t +1))Î [0,1]. w(t) is an inertia weight and initialized with 1.4. It is 
updated as follows: 
w(t +1) =
(w(t)-0.4)´ (MAXITER- Iter(t))
(MAXITER+0.4)
 
(4) 
where MAXITER  is the maximum iteration (generation) and Iter(t)  is the current 
iteration.  
3 An enhancement of Binary PSO (CPSO) 
Almost all previous works of gene expression data researches have selected a subset 
of genes to obtain excellent cancer classification. Therefore, in this article, we pro-
pose CPSO for selecting a near-optimal (small) subset of genes. It is proposed to 
overcome the limitations of BPSO and previous PSO-based methods [4],[7]-[10]. 
CPSO in our work differs from BPSO and the PSO-based methods on two parts: 1) 
we propose the constraint of elements of particle velocity vectors; 2) we introduce a 
rule for updating ( 1)dix t  , whereas BPSO and the PSO-based methods have used 
the original rule (Eq. 3) and no constraint of elements of particle velocity vectors. The 
constraint and rule are introduced in order to: 
1. increase the probability of x
i
d (t +1) = 0  (P(x
i
d (t +1) = 0)).  
2. reduce the probability of ( 1) 1dix t    ( ( ( 1) 1))
d
iP x t   . 
The increased and decreased probability values cause a small number of genes are 
selected and grouped into a gene subset. ( 1) 1dix t    means that the corresponding 
gene is selected. Otherwise, ( 1) 0dix t    represents that the corresponding gene is 
not selected. 
The constraint of elements of particle velocity vectors and the rule are proposed as 
follows: 
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(5) 
if Sig(v
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3
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Theorem 1. The constraint of elements of particle velocity vectors and the rule in-
crease P(x
i
d (t) = 0)  because the minimum value for P(x
i
d (t) = 0)  is 0.5 when 
v
i
d (t) = 0  (minP(x
i
d (t) = 0) ³ 0.5). Mean while, they decrease the maximum value 
for  P(x
i
d (t) =1)  to 0.5 (maxP(x
i
d (t) =1) £ 0.5).  Therefore, if v
i
d (t) > 0,  then 
P(x
i
d (t) = 0) >> 0.5 and P(x
i
d (t) =1)<< 0.5.  
Proof.  (Þ)  Figure 1 shows that a) The constraint of elements of particle velocity 
vectors and the rule in CPSO increase P(x
i
d (t) = 0);  b) Equations (1-3) in BPSO 
yield P(x
i
d (t) = 0) = P(x
i
d (t) =1) = 0.5.  For example, the calculations for 
P(x
i
d (t) = 0) and P(x
i
d (t) =1) in Fig. 2(a) are shown as follows: 
if v
i
d (t) =1,  then P(x
i
d (t) = 0) = 0.73 and P(x
i
d (t) =1) =1-P(x
i
d (t) = 0) = 0.27. 
if v
i
d (t) = 2, then P(x
i
d (t) = 0) = 0.88 and P(x
i
d (t) =1) =1-P(x
i
d (t) = 0) = 0.12. 
The fitness value of a particle (a gene subset) is calculated as follows: 
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)) / n) 
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in which A(X
i
)Î 0,1éë
ù
û  is leave-one-out-cross-validation (LOOCV) classification 
accuracy that uses the only genes in a gene subset (X
i
).  This accuracy is provided by 
support vector machine classifiers (SVM). R(X
i
)  is the number of selected genes in 
X
i
. n  is the total number of genes for each sample. w
1
 and w
2
 are two priority 
weights corresponding to the importance of accuracy and the number of selected 
genes, respectively, where w
1
Î [0.1,0.9] and w
2
=1-w
1
.  
 
 
 
 4 Experiments 
4.1 Data Sets and Experimental Setup 
The gene expression data sets used in this study are summarized in Table 1. They 
included binary-classes and multi-classes data sets. Experimental results that pro-
duced by CPSO are compared with an experimental method (BPSO) for objective 
comparisons. Additionally, the latest PSO-based methods from previous related works 
are also considered for comparison with CPSO [4],[7]-[10]. Firstly, we applied the 
gain ratio technique for pre-processing in order to pre-select 500-top-ranked genes. 
These genes are then used by CPSO and BPSO. Next, SVM is used to measure 
LOOCV accuracy on gene subsets that produced by CPSO and BPSO. For LOOCV, 
one sample in the training set is withheld and the remaining samples are used for 
building a classifier to classify the class of the withheld sample. By cycling through 
all the samples, we can get cumulative accuracy rates for classification accuracy of 
methods. In this research, LOOCV is used for measuring classification accuracy due 
to the small number of samples in gene expression data. Several experiments are in-
dependently conducted 10 times on each data set using CPSO and BPSO. Next, an 
average result of the 10 independent runs is obtained. High LOOCV accuracy, the 
small number of selected genes, and low running time are needed to obtain an excel-
lent performance.  
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Fig. 1.   The areas of  P(x
i
d (t) = 0)  and  P(x
i
d (t) =1)  based on sigmoid functions in a) 
CPSO; b) BPSO. The blue and green colors show the areas for P(x
i
d (t) = 0)  and 
P(x
i
d (t) =1)  respectively, and whereas the red color indicates the part of unsatisfied 
v
i
d (t) ³ 0  
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Table 1. The summary of gene expression data sets. 
Data set  No. classes No. samples  No.  genes Source 
Leukemia 
2 (ALL and 
AML) 
72 (67 ALL 
and 25 AML) 
7,129 
http://www.broad.mit.edu/cgi
-bin/cancer/datasets.cgi 
Lung  
2 (MPM 
and 
ADCA) 
181 (31 MPM 
and 150 
ADCA) 
12,533 
http://chestsurg.org/publicati
ons/2002-microarray.aspx. 
MLL 
3 (ALL, 
MLL, and 
AML) 
72 (24 ALL, 
20 MLL, and 
28 AML) 
12,582 
http://www.broad.mit.edu/cgi
-bin/cancer/datasets.cgi 
SRBCT 
4 (EWS, 
RMS, NB, 
and BL) 
82 (28 EWS, 
25 RMS, 18 
NB, and 11 
BL) 
2,308 
http://research.nhgri.nih.gov/
microarray/Supplement/ 
Colon 
2 (Normal 
and tumor) 
62 (22 normal 
and 40 tumor) 
2,000 
http://microarray.princeton.e
du/oncology/affydata/index.h
tml 
Note: 
MPM = malignant pleural mesothelioma. 
ADCA = adenocarcinoma. 
ALL = acute lymphoblastic leukemia. 
 
MLL = mixed-lineage leukemia. 
AML = acute myeloid leukemia. 
SRBCT = small round blue cell tumors. 
4.2 Experimental Results 
Based on the standard deviation of classification accuracies in Table 2, results that 
produced by CPSO were almost consistent on all data sets. Interestingly, all runs have 
achieved 100% LOOCV accuracy with less than 50 selected genes on the SRBCT 
data set. Moreover, over 97% classification accuracies have been obtained on other 
data sets, except for the colon data set. This means that CPSO has efficiently selected 
and produced a near-optimal gene subset from high-dimensional data (gene expres-
sion data). 
 Figure 2 shows that the averages of fitness values of CPSO increase dramatically 
after a few generations on all the data sets. A high fitness value is obtained by a com-
bination between a high classification rate and a small number (subset) of selected 
genes. The condition of the proposed constraint of elements of particle velocity vec-
tors that should always be positive real numbers started in the initialization method, 
and the new rule for updating particle’s positions provoke the early convergence of 
CPSO. In contrast, the averages of fitness values of BPSO was no improvement until 
the last generation due to P(x
i
d (t) = 0) = P(x
i
d (t) =1) = 0.5.   
For an objective comparison, CPSO is compared with BPSO. According to the Ta-
ble 3, overall, it is worthwhile to mention that the classification accuracy and the 
number of selected genes of CPSO are superior to BPSO in terms of the best, average, 
and standard deviation results on all the data sets. The classification accuracies of 
BPSO and CPSO were same on the lung and SRBCT data sets. However, the number 
of selected genes of BPSO was higher than CPSO to achieve the same accuracy.  
CPSO also produces smaller numbers of genes and lower running times compared 
to BPSO on all the data sets. CPSO can reduce its running times because of the fol-
lowing reasons: 
 CPSO selects the smaller number of genes compared to BPSO;  
Table 2. Experimental results for each run using CPSO on the leukemia, colon, lung, MLL, and 
SRBCT data sets 
Run# 
Leukemia Colon Lung MLL SRBCT 
#Acc 
(%) 
# 
Select-
ed 
Genes 
#Acc 
 (%) 
#Select-
ed 
Genes 
#Acc 
 (%) 
# 
Selected 
Genes 
#Acc 
 (%) 
#Select-
ed 
Genes 
#Acc 
 (%) 
#Select-
ed 
Genes 
1 100 10 90.32 4 99.45 9 97.22 32 100 20 
2 100 5 90.32 6 99.45 9 98.61 113 100 48 
3 100 3 88.71 28 99.45 7 97.22 38 100 42 
4 98.61 9 91.94 10 99.45 30 97.22 28 100 50 
5 98.61 9 88.71 8 99.45 8 97.22 6 100 21 
6 100 31 88.71 8 99.45 9 95.83 6 100 37 
7 98.61 11 88.71 7 98.90 8 97.22 11 100 32 
8 98.61 10 88.71 7 99.45 5 97.22 37 100 27 
9 98.61 8 88.71 5 99.45 15 97.22 88 100 21 
10 98.61 9 88.71 130 99.45 13 97.22 33 100 50 
Aver-
age 
± S.D. 
99.17 
± 
0.72 
10.50 
± 7.61 
89.36 
± 
1.13 
21.30 
± 38.80 
99.39 
± 
0.15 
11.30 
± 7.17 
97.22 
± 
0.66 
39.20 
± 35.04 
100 
± 0 
34.80 
± 12.30 
Note: Results of the best subsets is shown in shaded cells. A near-optimal subset that produces the highest classification accura-
cy with the smallest number of genes is selected as the best subset. #Acc and S.D. denote the classification accuracy and the 
standard deviation, respectively, whereas #Selected Genes and Run# represent the number of selected genes and a run number, 
respectively.  
 
 The computation of SVM is fast because it uses the small number of features 
(genes) that selected by CPSO for classification process. 
 
We also compare our work with previous related works that used PSO-based 
methods in their proposed methods [4],[7]-[10]. It is shown in Table 4. For all the 
data sets, the averages of the number of selected genes of our work were smaller than 
the previous works. Our work also have resulted the higher averages of classification 
accuracies on the leukemia and SRBCT data sets compared to the previous works. 
However, experimental results produced by Shen et al. were better than our work on 
the colon data set [7]. This is due to the incorporation of tabu search (TS) as a local 
improvement procedure enables the algorithm HPSOTS to overleap local optima and 
show satisfactory performance in classifying cancer classes and reducing the number 
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Fig. 2.     The relation between the average of fitness values (10 runs on average) and the num-
ber of generations for CPSO and BPSO 
  
of genes. Running time between CPSO and the previous works cannot be compared 
because it was not reported in their articles. 
According to Fig. 2 and Tables 2-4, CPSO is reliable for gene selection since it has 
produced the near-optimal solution from gene expression data. This is due to the pro-
posed constraint of elements of particle velocity vectors and the introduced rule in-
crease the probability x
i
d (t +1) = 0  (P(x
i
d (t +1) = 0)) . The increased probability 
value for x
i
d (t +1) = 0causes the selection of a small number of informative genes 
and finally produces a near-optimal subset (a small subset of informative genes with 
high classification accuracy) for cancer classification. 
 
 
Table 3. Comparative experimental results of CPSO and BPSO 
Data 
Method  
 
Evaluation 
CPSO BPSO 
Best #Ave S.D Best #Ave S.D 
Leu-
kemia 
#Acc (%)  100 99.17 0.72 98.61 98.61 0 
#Genes 3 10.50 7.16 216 224.70 5.23 
#Time  5.26 6.13 1.44 13.86 13.94 0.03 
Colon 
#Acc (%)  91.94 89.36 1.13 87.10 86.94 0.51 
#Genes 10 21.30 38.80 214 231 10.19 
#Time 8.78 9.26 0.70 30.58 30.63 0.27 
Lung 
#Acc (%)  99.45 99.39 0.18 99.45 99.39 0.18 
#Genes 5 11.30 7.17 219 223.33 4.24 
#Time 63.53 64.40 0.87 110.71 111.07 0.23 
MLL 
#Acc (%)  98.61 97.22 0.66 97.22 97.22 0 
#Genes 113 39.20 35.04 218 228.11 4.86 
#Time 9.51 11.64 4.98 19.37 19.90 0.35 
SRBC
T 
#Acc (%)  100 100 0 100 100 0 
#Genes 20 34.80 12.30 206 221.30 7.35 
#Time 21.67 21.76 1.32 44.86 44.88 0.01 
Note: The best result of each data set is shown in shaded cells. It is selected based on the following priori-
ty criteria: 1) the highest classification accuracy; 2) the smallest number of selected genes. #Acc and 
S.D. denote the classification accuracy and the standard deviation, respectively, whereas #Genes 
and #Ave represent the number of selected genes and an average, respectively. #Time stands for running 
time in the hour unit. 
 
5 Conclusion 
Overall, based on the experimental results, the performance of CPSO was superior to 
BPSO and previous PSO-based methods in terms of classification accuracy and the 
number of selected genes. CPSO was excellent because the probability x
i
d (t +1) = 0  
has been increased by the proposed constraint of elements of particle velocity vectors 
and the introduced rule. The constraint and rule have been proposed in order to yield a 
near-optimal subset of genes for better cancer classification. CPSO also obtains lower 
running times because it selects the small number of genes compared to BPSO. For 
future works, a modified representation of particle’s positions in PSO will be pro-
posed to reduce the number of genes subsets in solution spaces. 
Table 4. A Comparison Between Our Method (CPSO) and previous PSO-Based Methods 
Data 
Method 
 
Evaluation  
CPSO PSOTS 
 
[7] 
PSOGA 
 
[4] 
IBPSO 
 
[8] 
TS-
BPSO 
[9] 
BPSO-
CGA 
[10] 
Leu-
kemia 
Average #Acc (%) (99.17) (98.61) (95.10) - - - 
Best #Acc (%) 100 - - 100 100 100 
Average  #Genes (10.50) (7) (21) - - - 
 Best #Genes  3 - - 1034 2577 300 
Colon 
Average #Acc (%) (89.36) (93.55) (88.7) - - - 
Best #Acc (%) 91.94 - - - - - 
Average  #Genes (21.30) (8) (16.8) - - - 
 Best #Genes  10   - - - 
Lung 
Average #Acc (%) (99.39) - - - - - 
Best #Acc (%) 99.45 - - - - - 
Average #Genes (11.30) - - - - - 
Best #Genes 5 - - - - - 
MLL 
Average #Acc (%) (97.22) - - - - - 
Best #Acc (%) 98.61 - - - - - 
Average  #Genes (39.20) - - - - - 
 Best #Genes  113 - - - - - 
SRBC
T 
Average #Acc (%) (100) - - - - - 
Best #Acc (%) 100 - - 100 100 100 
Average  #Genes (34.80) - - - - - 
 Best #Genes  20 - - 431 1084 880 
Note: ‘-‘ means that a result is not reported in the related previous work. A result in ‘( )’ denotes an average result.  
PSOGA = A hybrid of PSO and GA. PSOTS = A hybrid of PSO and tabu search. IBPSO = An improved binary PSO.  
TS-BPSO = A combination of tabu search and BPSO. BPSO-CGA = A hybrid of BPSO and a combat genetic algorithm.  
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